AERIE PHARMACEUTICALS INC - COM (AERI)

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Number of holders
161
Total 13F shares, excl. options
32,439,327
Shares change
+4,634,141
Total reported value, excl. options
$1,224,263,296
Value change
+$176,293,073
Put/Call ratio
70%
Number of buys
109
Number of sells
38
Price
$37.74

Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q3 2016

As of 30 Sep 2016 AERIE PHARMACEUTICALS INC - COM (AERI) had 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 32,439,327 shares of stock of the company.
Largest 10 holders included JENNISON ASSOCIATES LLC, WELLINGTON MANAGEMENT GROUP LLP, Partner Fund Management, L.P., Foresite Capital Management III, LLC, Foresite Capital Management II, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., DEERFIELD MANAGEMENT CO, TPG Group Holdings (SBS) Advisors, Inc., VANGUARD GROUP INC, and BlackRock Fund Advisors.
This table shows 161 institutional shareholders of the security as of 30 Sep 2016.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.